2-Phenylethynesulfonamide
- 64984-31-2
- Pifithrin-mu
- 2-Phenylethynesulfonamide
- 2-phenylacetylenesulfonamide
- Pifithrin-|I
- Create:2005-03-26
- Modify:2025-01-18
- 2-phenylacetylenesulfonamide
- 2-phenylethynesulfonamide
- PES derivative PESA
- PFT-mu
- PFTmu
- pifithrin mu
- pifithrin-mu
- 64984-31-2
- Pifithrin-mu
- 2-Phenylethynesulfonamide
- 2-phenylacetylenesulfonamide
- Pifithrin-|I
- Phenylethynsulfonic Acid Amide
- Pifithrin-micro
- PFTmu
- phenylethynesulfonamide
- 2-phenylethyne-1-sulfonamide
- NSC303580
- NSC 303580
- Pifithrin-u
- MFCD00181531
- DTXSID40316450
- pifithrin mu
- PFTmu;2-Phenylethynesulfonamide
- PFT-mu
- PES derivative PESA
- PFT|I
- Ethynesulfonamide, 2-phenyl-
- Pifithrin-Ax
- Pifithrin- mu
- Pifithrin->m
- Pifithrin-_
- Pifithrin-.mu.
- Cambridge id 5147472
- Oprea1_468179
- Oprea1_544600
- PFT;2-Phenylethynesulfonamide
- SCHEMBL1230083
- CHEMBL1241268
- CHEBI:93704
- DTXCID80267573
- NSC 303580;PFT|I
- Pifithrin-Ax (NSC-303580)
- HMS1579M04
- HMS3263J21
- HMS3269J15
- HMS3413N19
- HMS3651B14
- HMS3677N19
- ALBB-014188
- BCP06510
- CCG-2233
- EX-A1232
- Tox21_501170
- HB3025
- s2930
- AKOS001417066
- LP01170
- NSC-303580
- SDCCGSBI-0633799.P001
- Pifithrin-mu - CAS 64984-31-2
- Pifithrin-mu, >=97% (HPLC), solid
- NCGC00162358-01
- NCGC00162358-02
- NCGC00162358-03
- NCGC00162358-05
- NCGC00162358-13
- NCGC00261855-01
- AC-36838
- AS-60233
- DA-76879
- HY-10940
- CS-0002901
- P2048
- SW148473-2
- EN300-27810
- BRD-K96799727-001-01-7
- BRD-K96799727-001-03-3
- BRD-K96799727-001-05-8
- BRD-K96799727-001-06-6
- BRD-K96799727-001-07-4
- Q27165400
- Z56915355
H302 (97.5%): Harmful if swallowed [Warning Acute toxicity, oral]
H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]
H335 (97.5%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation]
P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
(The corresponding statement to each P-code can be found at the GHS Classification page.)
Aggregated GHS information provided per 40 reports by companies from 3 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown.
Acute Tox. 4 (97.5%)
Skin Irrit. 2 (100%)
Eye Irrit. 2A (100%)
STOT SE 3 (97.5%)
Patents are available for this chemical structure:
https://patentscope.wipo.int/search/en/result.jsf?inchikey=ZZUZYEMRHCMVTB-UHFFFAOYSA-N
- CAS Common ChemistryLICENSEThe data from CAS Common Chemistry is provided under a CC-BY-NC 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc/4.0/2-Phenylethynesulfonamidehttps://commonchemistry.cas.org/detail?cas_rn=64984-31-2
- ChemIDplusChemIDplus Chemical Information Classificationhttps://pubchem.ncbi.nlm.nih.gov/source/ChemIDplus
- DTP/NCILICENSEUnless otherwise indicated, all text within NCI products is free of copyright and may be reused without our permission. Credit the National Cancer Institute as the source.https://www.cancer.gov/policies/copyright-reuse
- EPA DSSTox2-Phenylethynesulfonamidehttps://comptox.epa.gov/dashboard/DTXSID40316450CompTox Chemicals Dashboard Chemical Listshttps://comptox.epa.gov/dashboard/chemical-lists/
- European Chemicals Agency (ECHA)LICENSEUse of the information, documents and data from the ECHA website is subject to the terms and conditions of this Legal Notice, and subject to other binding limitations provided for under applicable law, the information, documents and data made available on the ECHA website may be reproduced, distributed and/or used, totally or in part, for non-commercial purposes provided that ECHA is acknowledged as the source: "Source: European Chemicals Agency, http://echa.europa.eu/". Such acknowledgement must be included in each copy of the material. ECHA permits and encourages organisations and individuals to create links to the ECHA website under the following cumulative conditions: Links can only be made to webpages that provide a link to the Legal Notice page.https://echa.europa.eu/web/guest/legal-noticeEthynesulfonamide, 2-phenyl-https://echa.europa.eu/substance-information/-/substanceinfo/100.164.056Ethynesulfonamide, 2-phenyl- (EC: 636-240-3)https://echa.europa.eu/information-on-chemicals/cl-inventory-database/-/discli/details/168877
- ChEBI2-phenylethynesulfonamidehttps://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:93704
- ChEMBLLICENSEAccess to the web interface of ChEMBL is made under the EBI's Terms of Use (http://www.ebi.ac.uk/Information/termsofuse.html). The ChEMBL data is made available on a Creative Commons Attribution-Share Alike 3.0 Unported License (http://creativecommons.org/licenses/by-sa/3.0/).http://www.ebi.ac.uk/Information/termsofuse.htmlChEMBL Protein Target Treehttps://www.ebi.ac.uk/chembl/g/#browse/targets
- Comparative Toxicogenomics Database (CTD)LICENSEIt is to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of NC State University.http://ctdbase.org/about/legal.jsp2-phenylacetylenesulfonamidehttps://ctdbase.org/detail.go?type=chem&acc=C545747
- Drug Gene Interaction database (DGIdb)LICENSEThe data used in DGIdb is all open access and where possible made available as raw data dumps in the downloads section.http://www.dgidb.org/downloadsCHEMBL:CHEMBL1241268https://www.dgidb.org/drugs/chembl:CHEMBL1241268
- Human Metabolome Database (HMDB)LICENSEHMDB is offered to the public as a freely available resource. Use and re-distribution of the data, in whole or in part, for commercial purposes requires explicit permission of the authors and explicit acknowledgment of the source material (HMDB) and the original publication (see the HMDB citing page). We ask that users who download significant portions of the database cite the HMDB paper in any resulting publications.http://www.hmdb.ca/citing2-Phenylethynesulfonamidehttp://www.hmdb.ca/metabolites/HMDB0256545
- Japan Chemical Substance Dictionary (Nikkaji)
- Nature Chemical Biology
- NIST Mass Spectrometry Data CenterLICENSEData covered by the Standard Reference Data Act of 1968 as amended.https://www.nist.gov/srd/public-law2-Phenylethynesulfonamidehttp://www.nist.gov/srd/nist1a.cfm
- Springer Nature
- Thieme ChemistryLICENSEThe Thieme Chemistry contribution within PubChem is provided under a CC-BY-NC-ND 4.0 license, unless otherwise stated.https://creativecommons.org/licenses/by-nc-nd/4.0/
- Wikidata2-phenylethynesulfonamidehttps://www.wikidata.org/wiki/Q27165400
- PubChem
- Medical Subject Headings (MeSH)LICENSEWorks produced by the U.S. government are not subject to copyright protection in the United States. Any such works found on National Library of Medicine (NLM) Web sites may be freely used or reproduced without permission in the U.S.https://www.nlm.nih.gov/copyright.html2-phenylacetylenesulfonamidehttps://www.ncbi.nlm.nih.gov/mesh/67545747
- GHS Classification (UNECE)GHS Classification Treehttp://www.unece.org/trans/danger/publi/ghs/ghs_welcome_e.html
- MolGenieMolGenie Organic Chemistry Ontologyhttps://github.com/MolGenie/ontology/
- PATENTSCOPE (WIPO)SID 392643986https://pubchem.ncbi.nlm.nih.gov/substance/392643986